The discovery of lead compound 2e was described. Its covalent binding to HCV NS5B polymerase enzyme was investigated by X-ray analysis. The results of distribution, metabolism and pharmacokinetics were reported. Compound 2e was demonstrated to be potent (replicon GT-1b EC50 = 0.003 μM), highly selective, and safe in in vitro and in vivo assays.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2013.10.060 | DOI Listing |
Publication Analysis
Top Keywords
hcv ns5b
8
ns5b polymerase
8
discovery irreversible
4
irreversible hcv
4
polymerase inhibitor
4
inhibitor discovery
4
discovery lead
4
lead compound
4
compound described
4
described covalent
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!